Skip to main content
HR 4771 113th Congress House Crime and Law Enforcement Criminal procedure and sentencing Drug trafficking and controlled substances Fraud offenses and financial crimes Government information and archives Trade restrictions

Designer Anabolic Steroid Control Act of 2014

Introduced: May 29, 2014 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 30 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 18, 2014
Signed by President.
Dec 18, 2014
Became Public Law No: 113-260.
Dec 13, 2014
Presented to President.
Dec 12, 2014
Message on Senate action sent to the House.
Dec 11, 2014
Senate Committee on the Judiciary discharged by Unanimous Consent.(consideration: CR S6696)
Dec 11, 2014
Passed Senate without amendment by Unanimous Consent.
Dec 11, 2014
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Dec 11, 2014
Senate Committee on the Judiciary discharged by Unanimous Consent. (consideration: CR S6696)
Sep 16, 2014
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Sep 15, 2014
Placed on the Union Calendar, Calendar No. 434.
Sep 15, 2014
DEBATE - The House proceeded with forty minutes of debate on H.R. 4771.
Sep 15, 2014
Motion to reconsider laid on the table Agreed to without objection.
Sep 15, 2014
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7459-7460)
Sep 15, 2014
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H7459-7460)
Sep 15, 2014
Considered under suspension of the rules. (consideration: CR H7459-7461)
Sep 15, 2014
Mr. Pitts moved to suspend the rules and pass the bill, as amended.
Sep 15, 2014
Reported (Amended) by the Committee on Judiciary. H. Rept. 113-587, Part II.
Sep 15, 2014
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-587, Part I.
Sep 10, 2014
Ordered to be Reported (Amended) by Voice Vote.
Sep 10, 2014
Committee Consideration and Mark-up Session Held.
Sep 9, 2014
Subcommittee on Crime, Terrorism, Homeland Security, and Investigations Discharged.
Jul 21, 2014
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Jul 15, 2014
Ordered to be Reported (Amended) by Voice Vote.
Jul 15, 2014
Committee Consideration and Mark-up Session Held.
Jul 14, 2014
Committee Consideration and Mark-up Session Held.
Jun 19, 2014
Forwarded by Subcommittee to Full Committee by Voice Vote .
Jun 19, 2014
Subcommittee Consideration and Mark-up Session Held.
May 30, 2014
Referred to the Subcommittee on Health.
May 29, 2014
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 29, 2014
Introduced in House
 Plain-English summary Congressional Research Service

(This measure has not been amended since it was passed by the House on September 15, 2014. The summary of that version is repeated here.)

Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to add specified substances to the list of those included within the definition of "anabolic steroid." Provides that a drug or hormonal substance (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that is not listed and that is derived from, or has a chemical structure substantially similar to, an anabolic steroid that is listed, shall be considered to be an anabolic steroid for purposes of such Act if it: (1) has been created or manufactured with the intent of producing a substance that either promotes muscle growth or otherwise causes a pharmacological effect similar to that of testosterone; or (2) has been, or is intended to be, promoted in any manner suggesting that consuming it will promote any pharmacological effect similar to that of testosterone.

Prohibits a substance from being considered to be a drug or hormonal substance for purposes of such Act if it is: (1) an herb or other botanical, a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical, or a combination of two or more such substances; or (2) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act and is not anabolic or androgenic. Requires any person claiming the benefit of such an exception to bear the burden of providing the appropriate evidence.

Authorizes the Attorney General to issue an order adding a drug or other substance to the definition of "anabolic steroid" upon finding that: (1) the substance satisfies the criteria for being considered an anabolic steroid, and (2) such addition will assist in preventing abuse or misuse of the substance.

Prohibits importing, exporting, manufacturing, distributing, dispensing, or possessing with intent to manufacture, distribute, or dispense any anabolic steroid, or any product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry (IUPAC). Prescribes penalties. Sets forth an exemption from such IUPAC nomenclature requirement if such product is labeled in the manner required under the Federal Food, Drug, and Cosmetic Act, as described in this Act.

Authorizes the Attorney General to: (1) collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled, and (2) publish a list of products containing an anabolic steroid that are not properly labeled.

What's happening now December 18, 2014

Became Public Law No: 113-260.

 Committees of jurisdiction 5
 Cosponsors 4
All 4 Democratic 3 Republican 1